Indu Remedies Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 11-07-2024
- Paid Up Capital ₹ 8.00 M
as on 11-07-2024
- Company Age 20 Year, 29 Days
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 3.77 M
as on 11-07-2024
- Satisfied Charges ₹ 4.04 Cr
as on 11-07-2024
- Revenue -56.56%
(FY 2017)
- Profit 86.58%
(FY 2017)
- Ebitda 109.24%
(FY 2017)
- Net Worth 1.07%
(FY 2017)
- Total Assets -4.15%
(FY 2017)
About Indu Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹3.77 M. The company has closed loans amounting to ₹4.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dinagarajan Mathivanan and Muthaya Mathivanan serve as directors at the Company.
- CIN/LLPIN
U51397TN2004PTC054711
- Company No.
054711
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2004
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Indu Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinagarajan Mathivanan  | Additional Director | 24-Oct-2017 | Current |
| Muthaya Mathivanan | Director | 29-Jul-2010 | Current |
Financial Performance of Indu Remedies.
Indu Remedies Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 56.56% decrease. The company also saw a substantial improvement in profitability, with a 86.58% increase in profit. The company's net worth moved up by a moderate rise of 1.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indu Remedies?
In 2017, Indu Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indu Data Fabricx Private LimitedActive 6 years 5 monthsDinagarajan Mathivanan and Muthaya Mathivanan are mutual person
Msdr Foods Private LimitedActive 4 yearsDinagarajan Mathivanan and Muthaya Mathivanan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Jun 2018 | ₹2.50 M | Open |
Central Bank Of India Creation Date: 01 Sep 2006 | ₹1.27 M | Open |
Canara Bank Creation Date: 05 Sep 2008 | ₹1.80 Cr | Satisfied |
How Many Employees Work at Indu Remedies?
Indu Remedies has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indu Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indu Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
